IYD
Iodotyrosine deiodinase 1
Also known as: C6orf71, DEHAL1, dJ422F24.1, IYD1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6PHW0
- Gene
- IYD
- Ensembl
- ENSG00000009765
- Chromosome
- 6
- Canonical length
- 289 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins
- Subcellular location
- Plasma membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes an enzyme that catalyzes the oxidative NADPH-dependent deiodination of mono- and diiodotyrosine, which are the halogenated byproducts of thyroid hormone production. The N-terminus of the protein functions as a membrane anchor. Mutations in this gene cause congenital hypothyroidism due to dyshormonogenesis type 4, which is also referred to as deiodinase deficiency, or iodotyrosine dehalogenase deficiency, or thyroid hormonogenesis type 4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
289 residues, UniProt reviewed canonical sequence.
>Q6PHW0|IYD
1 MYFLTPILVA ILCILVVWIF KNADRSMEKK KGEPRTRAEA RPWVDEDLKD SSDLHQAEED
61 ADEWQESEEN VEHIPFSHNH YPEKEMVKRS QEFYELLNKR RSVRFISNEQ VPMEVIDNVI
121 RTAGTAPSGA HTEPWTFVVV KDPDVKHKIR KIIEEEEEIN YMKRMGHRWV TDLKKLRTNW
181 IKEYLDTAPI LILIFKQVHG FAANGKKKVH YYNEISVSIA CGILLAALQN AGLVTVTTTP
241 LNCGPRLRVL LGRPAHEKLL MLLPVGYPSK EATVPDLKRK PLDQIMVTVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IYD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 442 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 442 nTPM
- liver: 31 nTPM
- kidney: 25 nTPM
- small intestine: 19 nTPM
- duodenum: 17 nTPM
- gallbladder: 8.3 nTPM
Single-cell type
- enterocytes: 102 nCPM
- proximal tubule cells: 99 nCPM
- hepatocytes: 36 nCPM
- goblet cells: 33 nCPM
- colonocytes: 26 nCPM
- gastric progenitor cells: 24 nCPM
Immune cell
- neutrophil: 2 nTPM
- basophil: 1.6 nTPM
- total PBMC: 1.3 nTPM
- NK-cell: 0.7 nTPM
- classical monocyte: 0.5 nTPM
- intermediate monocyte: 0.4 nTPM
Brain region
- pons: 4.3 nTPM
- cerebellum: 4.2 nTPM
- thalamus: 4.2 nTPM
- cerebral cortex: 4 nTPM
- white matter: 4 nTPM
- hippocampal formation: 3.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IYD.
Disease | AllUniProt
Conditions IYD is implicated in, by any mechanism.
- Thyroid dyshormonogenesis 4 (TDH4) MIM:274800
Disease | GeneticClinVar
8 pathogenic / likely-pathogenic of 110 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Iodotyrosine deiodination defect
- IYD-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.24
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- FMN binding
- oxidoreductase activity
- iodotyrosine deiodinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Nitroreductase-like
- Nitroreductase
- Nitroreductase/BluB
- Nitroreductase family
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IYD as an antibody target. Whether an autoantibody or antibody against IYD could matter depends on whether native IYD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IYD is annotated at the cell surface, where native IYD is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IYD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...